ORAMED PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $8.1M | $2.3M |
| FY2014 | — | $20.8M | $1.8M |
| FY2015 | — | $24.8M | $3.2M |
| FY2016 | — | $26.2M | $3.9M |
| FY2017 | — | $19.2M | $4.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $8.1M | $2.3M |
| FY2014 | — | $20.8M | $1.8M |
| FY2015 | — | $24.8M | $3.2M |
| FY2016 | — | $26.2M | $3.9M |
| FY2017 | — | $19.2M | $4.0M |